Intoxication with 5,5-diphenylhydantoin (Dilantin): Clinical features, blood levels, urinary metabolites, and metabolic changes in a child
- 30 April 1972
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 80 (4), 627-632
- https://doi.org/10.1016/s0022-3476(72)80060-x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The in vitro inhibition of insulin secretion by diphenylhydantoinJournal of Clinical Investigation, 1970
- Inhibition of Insulin Secretion by Diphenylhydantoin in the Isolated Perfused PancreasJournal of Clinical Endocrinology & Metabolism, 1970
- A new metabolite of 5,5-diphenylhydantoin (Dilantin++Dilantin is the Parke-Davis trade name for 5,5-diphenylhydatoin (phenytoin).)Biochemical and Biophysical Research Communications, 1970
- The rate of decline of diphenylhydantoin in human plasmaClinical Pharmacology & Therapeutics, 1970
- Hyperglycemia with Relative Hypoinsulinemia in Diphenylhydantoin ToxicityNew England Journal of Medicine, 1969
- Hyperglycemic, Nonketotic Coma Following Administration of Dilantin (Diphenylhydantoin)Diabetes, 1969
- The neurologic hazards ofdiphenylhydantoin in childhoodThe Journal of Pediatrics, 1968
- Fatal Diphenylhydantoin PoisoningPublished by American Medical Association (AMA) ,1966
- Diphenylhydantoin intoxication associated with hyperglycemiaThe Journal of Pediatrics, 1966
- Acute intoxication due to methsuximide and diphenylhydantoinThe Journal of Pediatrics, 1966